Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
Greinacher A, Selleng K, Mayerle J, Palankar R, Wesche J, Reiche S, Aebischer A, Warkentin TE, Muenchhoff M, Hellmuth JC, Keppler OT, Duerschmied D, Lother A, Rieg S, Gawaz MP, Mueller KAL, Scheer CS, Napp M, Hahnenkamp K, Lucchese G, Vogelgesang A, Flöel A, Lovreglio P, Stufano A, Marschalek R, Thiele T; Immune-Response in COVID-19 Vaccination Study Group.
Greinacher A, et al. Among authors: napp m.
Blood. 2021 Oct 7;138(14):1269-1277. doi: 10.1182/blood.2021012938.
Blood. 2021.
PMID: 34280256
Free PMC article.